Objective: To compare feeding tolerance, nutrient intake and growth in preterm infants (p32 weeks, p1750 g) fed either a standard nonhydrolyzed whey-casein (nHWC) or a partially hydrolyzed whey (pHW) preterm infant formula.
Introduction
Feeding intolerance is an important problem in preterm infants. 1 Recent studies suggest that feeding tolerance, as indicated by more rapid gastric emptying, shorter gastrointestinal transit times 2 and shorter time to establish full enteral feeds, 3 is better in preterm infants fed partially hydrolyzed whey (pHW) when compared with preterm infants fed standard intact casein-whey (nonhydrolyzed whey-casein, nHWC) protein-based formulas.
In the past the nutritional adequacy of hydrolyzed whey (HW) proteins in preterm infants has not been uniformly or consistently established. Rigo et al. 4 reported reduced protein utilization in preterm infants fed HW when compared with nHWC infant formula. Picaud et al. 5 reported that by increasing protein content 10%, equivalent protein and mineral retention and plasma aminoacid profiles were obtained with a HW when compared to a nHWC infant formula.
More recent manufacturing technology may allow for the optimization of nutrient availability and amino-acid profile. Szajewska et al. 6 fed preterm infants either an extensively hydrolyzed preterm infant formula, a partially hydrolyzed preterm infant formula, a standard preterm formula or fortified human milk for B12 weeks. All formulas were 60:40 whey/casein blends. No differences were noted in growth or serum chemistries between infants fed the hydrolyzed and standard preterm formulas, but growth was poorer in infants fed fortified human milk.
Maggio et al. 7 fed preterm infants either a standard nHWC or a HW preterm infant formula for B4 weeks. No significant differences were detected in blood urea nitrogen (BUN) but urinary excretion of essential amino acids was less and weight gain was greater (20.5 ± 3.3 >17.4 ± 3.4 g kg -1 per day; P<0.05) in infants fed the nHWC formula. 7 More recently, our group examined nutrient balance in preterm infants fed two pHW formulas containing different levels of protein, 3.0 and 3.6 g per 100 kcal. 8 Irrespective of level, protein utilization was at least as good as that previously noted by us in preterm infants 9 and better than that previously noted by other investigators 4, 5 or the data recently summarized by Rigo and Senterre. 10 Given the potentially beneficial effects of a hydrolyzed formula on feeding tolerance but the need to ascertain the ability of pHW formulas to support growth in premature infants, the current growth study was undertaken. It was hypothesized that feeding tolerance, assessed by the frequency of interruption of feeds, would be better, enteral nutrient intake would be more consistently maintained and growth, therefore, would be better in infants fed a pHW when compared to a nHWC preterm infant formula.
Methods

Design
This prospective, double-blind, randomized, controlled and parallel trial was conducted at the Sheldon B. Korones Newborn Center, The Regional Medical Center, University of Tennessee, Memphis. The study was approved by the Institutional Review Board of the University of Tennessee Center for Health Sciences. Written informed consent was obtained from the parents or legally appointed guardian.
Subjects
Premature infants (birth weight p1750 g, estimated gestational age of p34 weeks) were considered eligible. Only those infants of chronologic age p42 days, tolerating X120 kcal kg À1 per day (equivalent to >150 cm 3 kg À1 per day with 24 kcal per oz formula) of enteral feeds X24 h and for whom breast milk comprised p25% of weekly intake were enrolled. Gestational age was determined using maternal dates and intrauterine ultrasound. Infants with cardiac failure, periventricular or intraventricular hemorrhage grade III or IV, renal disease, sepsis, necrotizing enterocolitis, hepatic dysfunction, lung disease requiring steroids or continuous diuretic therapy or participation in another trial which might affect nutritional status were excluded.
Procedure
Infants were randomized to one of two formulas by a computergenerated randomization scheme stratified by gender and blockrandomized by birth weight (<1250 and 1250 to 1750 g) using one of four different colored labels. Color assignment was kept hidden until randomization by means of sequentially labeled, sealed opaque envelopes.
Ready-to-feed formula was provided in cartons containing 6 Â 89 ml bottles, color-coded by the manufacturer. Infants were primarily formula-fed but eight infants received fortified human milk, 12 to 75 ml per day on a total of 36 subject days. In all cases the amount of human milk was less than 25% of weekly caloric intake, as determined by study protocol.
The compositions of the study formulas are presented in Table 1 . The compositions differed primarily in the type of protein fed; that is, a nonhydrolyzed protein with a whey/casein ratio of 60:40 vs a partially hydrolyzed protein that was 100% whey. Otherwise, they were nearly identical in osmolality, vitamin and mineral content. Both contained nucleotides and the long-chain polyunsaturated fatty acids docosahexaenoic acid and arachidonic acid.
The study began once the study formula was fed and lasted a minimum period of 21 days. During hospital stay, intake volume was prescribed by one of the research group and monitored three times per week to ensure an intake of 150 to 165 ml kg À1 per day. Infants were fed according to a standard unit feeding protocol. Infants were initially fed by continuously using an orogastric tube until B31 to 32 weeks gestation. At this point, bolus feeds were introduced, initially hourly progressing to three hourly. Once threehourly feeds were established nipple feeds were introduced.
Feeding tolerance was monitored daily. Feeding intolerance was defined as any interruption in enteral feeds once the study formula was fed. If hospital discharge occurred before 21 days of feeding on the study formula, parents were provided with six to eight cartons of formula with instructions to feed on demand and return at predetermined designated times.
Sample size estimation and statistical analysis It was hypothesized that feeding intolerance would be less with the pHW formula but this is difficult to define in a precise and reproducible fashion in the clinical setting. It was reasoned that to be significant intake needed to be curtailed to the extent that growth was affected. Sample size estimation was, therefore, based upon weight gain, a difference of 6 g per day, as well as a standard deviation (s.d.) of 6 g per day, a statistical power of 0.8 and a 95% level of significance. The requirement was 72 infants (36 boys, 36 girls). Descriptive statistics were used to describe means, s.d. and so on as well as covariates at baseline. Data were analyzed on an intentto-treat and a per protocol basis. Analysis of covariance with 3-week weight, weight gain and so on as the dependent variable, type of formula as the group membership, sex and birth weight as stratified variables. The data were also analyzed using corrected age as a covariant. Results were considered significant at a 95% confidence level.
Results
A total of 80 infants, 38 in the control and 42 in the treatment group, were enrolled between 1 July 2004 and 15 December 2005. Six infants did not complete the study. Two infants were randomized but never started because they were too old when the study formula could be fed (1, control; 1, treatment), two were discharged home on the study formula but never returned for follow-up (1, control; 1, treatment), one infant developed Group B streptococcal sepsis (control group) and one infant developed necrotizing enterocolitis (treatment group). In effect, 74 infants completed the study, 72 on a per protocol basis with 38 in the treatment and 34 in the control group.
The characteristics of the two study groups are presented in Table 2 . No differences were detected in birth weight, gestational age or postnatal age, corrected age or anthropometric measurements at the beginning of the study. No differences were detected in sex or racial distributions between the study groups.
During the study, four infants had their feedings interrupted (1, control group; 3, treatment group). The infant in the control group developed sepsis and was withdrawn from the study. One infant in treatment group developed necrotizing entercolitis and was withdrawn from the study. In the two other infants, no pathology was detected and feeds were restarted within 24 h.
The intake data are presented in Table 3 . No differences were detected in nutrient intake, anthropometrics or serum biochemical determinations between the sexes. Data have therefore been combined. Intakes increased somewhat during the study but no differences were detected in either energy or protein intakes between the two study groups over the 3-week study period.
Growth in the study groups is presented in Table 4 . No significant differences were noted in weight or weight gain between the groups. Given the observed variance a difference of X3 g per day would have been statistically significant. No differences were detected in crown-heel length or occipitofrontal circumference or gain between the groups.
Serum chemistries are presented in Table 5 . BUN tended to fall in the control but did not change significantly in the treatment group. At the end of the study; that is, week 3, BUN was lower in the control than treatment group (P<0.001). Total serum proteins and serum albumin fell somewhat during the study but at the end of study levels were greater in control than the treatment group (P<0.05). At the end of the study, no differences were detected in serum prealbumin (9.5±1.8 vs 9.2±2.3 mg per 100 ml), retinol- 
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binding protein (1.7 ± 0.5 vs 1.5 ± 0.4 mg per 100 ml) or transferrin (173±43 vs 166±33 mg per 100 ml) levels between the two groups.
The remaining serum chemistries are also presented in Table 5 . Serum calcium did not change in control group and at the end of the study was somewhat greater than in the treatment group (P<0.001). At the end of the study, serum phosphorus was also greater in the control than treatment group (P<0.001). Serum alkaline phosphatase did not change significantly over the course of the study and no significances were detected between the groups at the end of the study. No differences were detected in prealbumin, RBP, transferrin or fatty acid profile analyzed at the end of the study.
Plasma amino-acid analyses are presented in Table 6 . No significant differences were noted in total amino acid, indispensable; that is, sum of threonine, valine, isoleucine, leucine, phenylalanine, lysine, methionine, tryptophan, cysteine, tyrosine and histidine, or dispensable; that is, alanine, asparaginine, aspartate, glutamine, glutamate, glycine, hydroxyproline, ornithine, proline and serine, amino acids. The laboratory was unable to provide arginine levels. However, plasma asparigine (73±7.2 >69±7.8 mmol l À1 ; P<0.05) and glutamate (96±9.3 >91 ± 5.2 mmol l À1 ; P<0.005) were greater in the control than treatment group. No differences in any individual amino acid were Calcium (mg per 100 ml) Control 10±0.4 9.9±0.4 9.8±0.3 9.9±0.4 0.001 Treatment 9.9 ± 0.5 9.6 ± 0.4 9.5 ± 0.4 9.5 ± 0.5
Phosphorus (mg per 100 ml) Control 7.1 ± 0.7 6.7 ± 0.6 6.6 ± 0.6 6.6 ± 0. Abbreviations: BUN, blood urea nitrogen; NS, not significant; TSP, total serum proteins. a At the end of the study. Growth in preterm infants KN Florendo et al detected between the two formula groups when the Sidak stepdown procedure was applied to compensate for multiple comparisons.
Discussion
Even after full enteral feedings have been established, feeds are commonly interrupted in preterm infants. 1 In many instances, no underlying pathology is detected and feeds are soon restarted. Yet, it takes time to reestablish full intakes and the accrued nutrient deficit increases. 1 We reasoned that if tolerance were better, 2, 3 interruptions would be less frequent, intake would more consistently maintained and, therefore, growth would be greater with the PHW formula. However in this study, tolerance was excellent with both formulas, feeds were interrupted on only four occasions and no differences were detected in intake or growth between the treatment groups. Yet, despite similar energy and protein intakes BUN was higher, whereas total serum proteins and albumin were lower in infants fed the pHW formula. This is consistent with the idea that protein utilization and metabolism are different with HW when compared to standard nHWC formulas. Rigo and Senterre 10 summarized their extensive experience in this area noting decreased absorption, protein utilization (retention/intake) and protein efficiency (retention/absorption) in very low birth weight infants fed various hydrolyzed protein formulas when compared to nonhydrolyzed powdered or liquid formulas.
Lacroix et al. 11 more recently reported transient hyper-followed by hypo-aminoacidemia and more rapid transfer of dietary nitrogen to serum proteins, serum and urinary urea with whey when compared to micellar casein or total milk protein in adults. These authors concluded that, despite the high Protein Digestibility Corrected Amino Acid Score of the whey proteins, the rate of amino-acid delivery was too rapid to sustain anabolic requirement during the 8-h postprandial period.
However, important differences exist in protein metabolism between preterm infants and adults. Protein turnover rates are significantly greater in preterm infants. [12] [13] [14] The method of feeding is also different; that is, many very low birth weight infants are fed by continuous gastric infusion or every 1 to 2 h and the protein/amino-acid load is likely to be less. At higher turnover rates and a lower amino-acid load net utilization is likely to be greater. Such may very well have been the case in a more recent nutrient balance study. 8 In this growth study, infants were fed the same pHW protein as used in the previously conducted balance study at different levels of protein intake, 3.0 and 3.6 g per 100 kcal. 8 Irrespective of level of intake, nitrogen utilization (B70%) and efficiency (B85%) were significantly greater than those published by Rigo and Senterre, 10 62 and 74%, respectively, and similar to those reported by us in preterm infants fed standard NHWC preterm formulas, B68 and B82%, respectively. 9 At an intake of 3.0 g per 100 kcal, protein assimilation (2.7 g kg À1 per day) somewhat exceeded that 'in utero' (2.5 g kg À1 per day) and was paralleled by normal growth (27 g per day) and serum chemistries. 8, 15 A further examination of the biochemical differences is therefore warranted. Statistically significant but small differences were noted in BUN, total protein, albumin, calcium and phosphorus levels between the groups. However, serum levels for both groups were well within normal limits for preterm infants. [16] [17] [18] [19] [20] [21] Furthermore, no differences were detected in serum prealbumin, retinol-binding protein, transferrin, alkaline phosphatase at the end of the study nor were there differences in weight or length gain between the groups. Collectively, these data suggest that although statistically significant in a large group of infants, the differences are not clinically meaningful. Yet, it is important to serially monitor these biochemical markers as part of routine care in these rapidly growing high-risk infants.
The findings of this study are important. Data from Mihatsch et al. 3 suggest that time to full enteral feeds is shorter when infants are fed a HW infant formula but its' use is tempered by concerns for nutritional adequacy. 4, 22 Data from this study suggest that a pHW formula can be fed from the beginning without such concerns, a critical consideration in the early establishment of adequate enteral intakes in these underfed infants.
Feeding intolerance is common after full enteral feeds have been established. Data from this study do not support the idea that feeding intolerance is less but the overall incidence of intolerance was much lower than expected. Tolerance might be better studied under conditions where the incidence of intolerance is higher. Irrespective, quicker reestablishment of full enteral intakes may be possible with the pHW formula after an episode of feeding intolerance. 3 Hydrolyzed protein formulas are commonly fed postoperatively to preterm infants who have undergone gastrointestinal surgery. However, these formulas were designed to meet the nutritional needs of term infants and many preterm infants are systematically underfed. The pHW formula studied in this trial was designed to meet the unique nutritional needs and supports acceptable growth of the preterm infant. This is an important step forward in the care of these undernourished infants.
